Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Racioppi

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Urologia|December 20, 2022
Management of metastatic urothelial carcinoma: Current approach, emerging agents, and future perspectivesRoberto Iacovelli, Carlo Maria Cicala, Chiara Ciccarese, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|December 24, 2016
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomesGiuseppe Palermo, Angelo Totaro, Emilio Sacco, et al.
Expert Opinion on Drug Discovery|February 25, 2014
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinenceEmilio Sacco, Riccardo Bientinesi, Daniele Tienforti, et al.
Urologia Internationalis|June 3, 2010
Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approachMarco Racioppi, Andrea Volpe, Emanuele Cappa, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|August 23, 2012
Hot topics in urological health economics. A mini reviewMarco Racioppi, Giuseppe Palermo, Alessandro D'Addessi, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|May 31, 2019
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expressionGiuseppe Palermo, Pierfrancesco Bassi, Marco Racioppi, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|November 29, 2007
The cost of treatment and follow-up of bladder cancer in ItalyMarco Racioppi, Andrea Volpe, Roberto Falabella, et al.
Urologia|September 21, 2016
Mitomycin C: new strategies to improve efficacy of a well-known therapyMauro Ragonese, Marco Racioppi, Pier Francesco Bassi, et al.
Clinical Genitourinary Cancer|July 25, 2022
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder CancerMauro Ragonese, Luca Di Gianfrancesco, Giuseppe Palermo, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|June 9, 2009
Progression, risk factors and subsequent medical management of symptomatic benign prostatic hyperplasiaFrancesco Pinto, Marco Racioppi, Emilio Sacco, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Urologia|December 20, 2022
Management of metastatic urothelial carcinoma: Current approach, emerging agents, and future perspectivesRoberto Iacovelli, Carlo Maria Cicala, Chiara Ciccarese, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|December 24, 2016
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomesGiuseppe Palermo, Angelo Totaro, Emilio Sacco, et al.
Expert Opinion on Drug Discovery|February 25, 2014
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinenceEmilio Sacco, Riccardo Bientinesi, Daniele Tienforti, et al.
Urologia Internationalis|June 3, 2010
Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approachMarco Racioppi, Andrea Volpe, Emanuele Cappa, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|August 23, 2012
Hot topics in urological health economics. A mini reviewMarco Racioppi, Giuseppe Palermo, Alessandro D'Addessi, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|May 31, 2019
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expressionGiuseppe Palermo, Pierfrancesco Bassi, Marco Racioppi, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|November 29, 2007
The cost of treatment and follow-up of bladder cancer in ItalyMarco Racioppi, Andrea Volpe, Roberto Falabella, et al.
Urologia|September 21, 2016
Mitomycin C: new strategies to improve efficacy of a well-known therapyMauro Ragonese, Marco Racioppi, Pier Francesco Bassi, et al.
Clinical Genitourinary Cancer|July 25, 2022
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder CancerMauro Ragonese, Luca Di Gianfrancesco, Giuseppe Palermo, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|June 9, 2009
Progression, risk factors and subsequent medical management of symptomatic benign prostatic hyperplasiaFrancesco Pinto, Marco Racioppi, Emilio Sacco, et al.
Pageof 12